1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate

Evidence summary [ESUOM4] Published: 29 January 2013

  • Advice
  • Information for the public
  • Key points from the evidence
  • Overview for healthcare professionals
  • Relevance to NICE guidance programmes
  • Intervention and alternatives
  • Evidence review: efficacy
  • Evidence: safety
  • Evidence: economic issues
  • Evidence strengths and limitations
  • Summary for patients
  • References
  • Changes after publication
  • Development of this evidence summary
  • Appendix: Search strategy and evidence selection
  • About 'Evidence summaries: unlicensed or off-label medicines'
Download (PDF)

Advice

  • Next

Relevance to NICE guidance programmes

Relevance to NICE guidance programmes

No NICE guidance on preventing or treating recurrence of hypomagnesaemia was identified.


  • Next